Oxidative stress is a triggering factor for LPS-induced Mrp2 internalization in the cryopreserved rat and human liver

Shuichi Sekine1, Kentaro Yano, Junjiro Saeki

  • 1Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.

Insights

Dimerumic acid (DMA) prevents endotoxin-induced oxidative stress, which disrupts multidrug resistance-associated protein 2 (Mrp2) localization in rat and human liver. This antioxidant effect protects bile-salt-independent bile flow.

Area of Science:

  • Hepatology
  • Biochemistry
  • Toxicology

Background:

  • Cholestasis, linked to inflammation and oxidative stress, involves impaired bile flow.
  • Multidrug resistance-associated protein 2 (Mrp2) is a key biliary transporter for bile-salt-independent bile flow.
  • LPS-induced oxidative stress causes Mrp2 internalization in rat liver, but its effect in human liver is unclear.

Purpose of the Study:

  • To investigate the effect of dimerumic acid (DMA), an antioxidant, on endotoxin-induced Mrp2 internalization in rat and human liver slices.
  • To determine if LPS-induced Mrp2 internalization occurs in human liver under acute oxidative stress.

Main Methods:

  • Treatment of rat and human liver slices with lipopolysaccharide (LPS) and dimerumic acid (DMA).
  • Analysis of canalicular Mrp2 localization and protein expression.
  • Assessment of filamentous actin integrity.

Main Results:

  • LPS treatment disrupted canalicular Mrp2 localization in both rat and human liver slices within 1.5 hours.
  • Mrp2 protein expression and filamentous actin integrity remained unchanged.
  • DMA pretreatment effectively counteracted the LPS-induced Mrp2 redistribution.

Conclusions:

  • Endotoxin-induced oxidative stress causes rapid, short-term Mrp2 internalization from the canalicular surface in both rat and human liver.
  • DMA exhibits protective effects against LPS-induced Mrp2 internalization, suggesting its therapeutic potential in cholestasis associated with oxidative stress.